{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:55:36Z","timestamp":1775156136374,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007883","name":"Stichting Coolsingel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.radonc.2021.01.030","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T23:10:24Z","timestamp":1612480224000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma"],"prefix":"10.1016","volume":"157","author":[{"given":"Jackelien G.M.","family":"van Beek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-5281","authenticated-orcid":false,"given":"Wishal D.","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Angi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline M.","family":"van Rij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9760-9781","authenticated-orcid":false,"given":"Nicole C.","family":"Naus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-2924","authenticated-orcid":false,"given":"Andrzej","family":"Kacperek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger D.","family":"Errington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-7131","authenticated-orcid":false,"given":"Bertil","family":"Damato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6867-3792","authenticated-orcid":false,"given":"Emine","family":"Kili\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.radonc.2021.01.030_b0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2005.01.058","article-title":"Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma","volume":"63","author":"Muller","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.radonc.2021.01.030_b0010","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.clon.2016.01.034","article-title":"Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma","volume":"28","author":"Verma","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.radonc.2021.01.030_b0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjopt.2013.06.014","article-title":"Proton beam radiotherapy of uveal melanoma","volume":"27","author":"Damato","year":"2013","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"10.1016\/j.radonc.2021.01.030_b0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0002-9394(85)90357-5","article-title":"Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation","volume":"99","author":"Seddon","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.radonc.2021.01.030_b0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0161-6420(90)32512-5","article-title":"Relative survival rates after alternative therapies for uveal melanoma","volume":"97","author":"Seddon","year":"1990","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/eye.2012.242","article-title":"Personalized treatment of uveal melanoma","volume":"27","author":"Damato","year":"2013","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.radonc.2021.01.030_b0035","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/bjo.2008.153429","article-title":"Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up","volume":"93","author":"Krema","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(00)00164-X","article-title":"Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma","volume":"55","author":"Zehetmayer","year":"2000","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2021.01.030_b0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","article-title":"Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma","volume":"98","author":"Yazici","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2021.01.030_b0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/153303460600500409","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma","volume":"5","author":"Henderson","year":"2006","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijrobp.2005.01.057","article-title":"Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study","volume":"63","author":"Weber","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2012.249","article-title":"Effects of radiotherapy on uveal melanomas and adjacent tissues","volume":"27","author":"Groenewald","year":"2013","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.radonc.2021.01.030_b0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2021.01.030_b0070","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","article-title":"Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome","volume":"160","author":"Seibel","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.radonc.2021.01.030_b0075","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radonc.2021.01.030_b0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archopht.116.3.366","article-title":"Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates","volume":"116","author":"Egan","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.radonc.2021.01.030_b0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye retention after proton beam radiotherapy for uveal melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2011.06.038","article-title":"Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results","volume":"102","author":"Muller","year":"2012","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.radonc.2021.01.030_b0095","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/eye.2015.109","article-title":"Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma","volume":"29","author":"Sikuade","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.radonc.2021.01.030_b0100","series-title":"TNM classification of malignant tumours","first-page":"221","article-title":"Malignant Melanoma of the Uvea","author":"Brierley","year":"2017"},{"key":"10.1016\/j.radonc.2021.01.030_b0105","series-title":"Uveal melanoma, in AJCC cancer staging manual","first-page":"805","author":"Kivel\u00e4","year":"2016"},{"issue":"1","key":"10.1016\/j.radonc.2021.01.030_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijrobp.2011.06.1957","article-title":"Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated","volume":"83","author":"Dunavoelgyi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.030_b0115","first-page":"43","article-title":"Long-term risk of local failure after proton therapy for choroidal\/ciliary body melanoma","volume":"100","author":"Gragoudas","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.radonc.2021.01.030_b0120","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0b013e3182340cc1","article-title":"Vitreous hemorrhage after plaque radiotherapy for uveal melanoma","volume":"32","author":"Bianciotto","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.radonc.2021.01.030_b0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2016.02.027","article-title":"Outcomes after proton beam therapy for large choroidal melanomas in 492 Patients","volume":"165","author":"Bensoussan","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.radonc.2021.01.030_b0135","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00417-017-3737-3","article-title":"Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors","volume":"255","author":"Riechardt","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.radonc.2021.01.030_b0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaophthalmol.2019.5132","article-title":"Visual outcome at 4 years following plaque radiotherapy and prophylactic intravitreal bevacizumab (every 4 months for 2 years) for uveal melanoma: comparison with nonrandomized historical control individuals","volume":"138","author":"Shields","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.radonc.2021.01.030_b0145","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ophtha.2009.12.015","article-title":"Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma","volume":"117","author":"Kim","year":"2010","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.radonc.2021.01.030_b0150","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.radonc.2021.01.030_b0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","article-title":"Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement","volume":"127","author":"Gunduz","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.radonc.2021.01.030_b0160","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0161-6420(92)31832-9","article-title":"Radiation maculopathy after proton beam irradiation for choroidal melanoma","volume":"99","author":"Guyer","year":"1992","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.radonc.2021.01.030_b0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.86.4.448","article-title":"Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window","volume":"86","author":"Boyd","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.radonc.2021.01.030_b0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oret.2019.02.009","article-title":"Aflibercept for radiation maculopathy study: a prospective. Randomized clinical study","volume":"3","author":"Murray","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.radonc.2021.01.030_b0175","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","article-title":"Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients","volume":"119","author":"Damato","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.radonc.2021.01.030_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-1088-9","article-title":"Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma","volume":"13","author":"Akbaba","year":"2018","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2021.01.030_b0185","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/aos.13823","article-title":"Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients","volume":"96","author":"van Beek","year":"2018","journal-title":"Acta Ophthalmol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:16:47Z","timestamp":1759123007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021060382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"alternative-id":["S0167814021060382"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}